"Market Intelligence that Adds Flavour to Your Success"

Europe Fucoidan Market Size, Share & COVID-19 Impact Analysis, By Form (Powder, Capsule, and Others), By Application (Pharmaceutical, Dietary Supplements, and Cosmetics), and Country Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107877

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview on the Parent Market
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Industry SWOT Analysis
    5. Recent Industry Developments - Policies, Mergers & Acquisitions, and  New Product Launches
    6. Market Analysis and Insights (in Relation with COVID-19)
      1. Impact of COVID-19 on the Market
      2. Supply Chain Challenges due to the Pandemic
      3. Potential Opportunities Due to COVID-19
  5. Europe Fucoidan Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Size Estimates and Forecast 
      1. By Form (Value)
        1. Powder
        2. Capsule
        3. Others
      2. By Application (Value)
        1. Pharmaceutical
        2. Dietary Supplements
        3. Cosmetics
      3. By Country (Value)
        1. Germany
        2. France
        3. U.K.
        4. Russia
        5. Italy
        6. Rest of Europe
  6. Competitive Matrix
    1. Business Strategies Adopted by Leading Players
    2. Europe Fucoidan Market Ranking Analysis, By Key Manufacturer, 2024
  7. Company Profiles
    1. Merck Group
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    2. Biosynth
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    3. Hi-Q Marine Biotech International Ltd
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    4. Kraeber & Co GmbH
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    5. Dextra Laboratories Ltd
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    6. Molekula Group
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    7. Hepatica
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    8. Absonutrix LLC
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    9. Nutrality
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
  8. Strategic Recommendations
  9. Appendix
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview on the Parent Market
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Industry SWOT Analysis
    5. Recent Industry Developments - Policies, Mergers & Acquisitions, and  New Product Launches
    6. Market Analysis and Insights (in Relation with COVID-19)
      1. Impact of COVID-19 on the Market
      2. Supply Chain Challenges due to the Pandemic
      3. Potential Opportunities Due to COVID-19
  5. Europe Fucoidan Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Size Estimates and Forecast 
      1. By Form (Value)
        1. Powder
        2. Capsule
        3. Others
      2. By Application (Value)
        1. Pharmaceutical
        2. Dietary Supplements
        3. Cosmetics
      3. By Country (Value)
        1. Germany
        2. France
        3. U.K.
        4. Russia
        5. Italy
        6. Rest of Europe
  6. Competitive Matrix
    1. Business Strategies Adopted by Leading Players
    2. Europe Fucoidan Market Ranking Analysis, By Key Manufacturer, 2024
  7. Company Profiles
    1. Merck Group
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    2. Biosynth
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    3. Hi-Q Marine Biotech International Ltd
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    4. Kraeber & Co GmbH
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    5. Dextra Laboratories Ltd
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    6. Molekula Group
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    7. Hepatica
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    8. Absonutrix LLC
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
    9. Nutrality
      1. Overview
      2. Description
      3. Type Portfolio
      4. Financials (Data as available in public domain and/or on paid databases)
      5. Recent Developments
  8. Strategic Recommendations
  9. Appendix
Read Less

Figure 1: Europe Fucoidan Market (USD Million), 2024 and 2032

Figure 2: Europe Fucoidan Market, By Form, 2024 and 2032, (USD Million)

Figure 3: Europe Fucoidan Market , By Application, 2024 and 2032, (USD Million)

Figure 4: Retail Sales of Organic Products of Top Three Countries in Europe, 2019, (USD Billion)

Figure 5: Europe Algae (Including Seaweed and Microalgae) Production Share, By Country, 2019

Figure 6: Total Number of Diabetes Patients by country (in Thousands) (2021)

Figure 7: Major Brown Seaweed Species Cultivated in Europe in 2019, in Tonnes

Figure 8: Major Brown Seaweed Species Cultivated in Norway in 2019, in Tonnes

Figure 9: Major Brown Seaweed Species Cultivated in Ireland in 2019, in Tonnes

Figure 10: Major Brown Seaweed Producing European Countries in 2019, in Tonnes

Figure 11: Major Brown Seaweed Species Cultivated in France in 2019, in Tonnes

Figure 12: Major Brown Seaweed Species Cultivated in Russia in 2019, in Tonnes

Figure 13: Fucoidan Supply Chain

Figure 14: Work flow and Timeframe Of The Novel Food Authorization Procedure in Europe

Figure 15: Europe Fucoidan Market Value (USD Million), by Form, 2024 & 2032

Figure 16: Europe Fucoidan Market Value Share (%), by Form, 2024

Figure 17: Europe Fucoidan Market Value (USD Million), by Application, 2024 & 2032

Figure 18: Europe Fucoidan Market Value Share (%), by Application, 2024

Figure 19: Europe Fucoidan Market Value (USD Million), by Country, 2024 & 2032

Figure 20: Europe Fucoidan Market Value Share (%), by Country, 2024

Figure 21: Key Strategies Adopted by Fucoidan Companies, 2019-2024

Table 1: Seaweed Species harvesting techniques in Europe

Table 2: Main Macroalgae Uses in Europe

Table 3: Europe Fucoidan Market Revenue (USD Million) Forecast, By Form, 2019-2032

Table 4: Europe Fucoidan Market Revenue (USD Million) Forecast, By Application, 2019-2032

Table 5: Europe Fucoidan Market Revenue (USD Million) Forecast, By Country, 2019-2032

Table 6: Company Ranking Analysis, 2024

Europe Fucoidan Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 96
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
Sumitomo
Daesang
Ferrero
Fuji film
Agthia Group PJSC
Ajinomoto
Barclays
Brooks International
DSM
Koch Industries, Inc.
Korn Ferry
McCain
Mitsubishi Corporation
Nestle
Nissin Foods
Samyang Foods
Singapore Food Agency
Starbucks
The Kraft Heinz Company
Yum Brands

Related Reports